Diseases of the Colon & Rectum · 1977 · 10 citations · 14 references
MedicineOncologySurgeryChemotherapyGastrointestinal OncologyMetastasisCancer ImmunotherapyColorectal CancerCombination ChemotherapyGastric CancerMetastatic Gastrointestinal CancerPancreatic CancerCombination ChemoimmunotherapyImmunotherapy For Gastric CancerIntraperitoneal AdministrationMetastatic Gastric CancerTherapeutic Immunostimulation
The survival of patients who have cancers of the gastrointestinal tract is poor even after surgical resection of all gross disease. In an initial consecutive series of patients with metastatic or recurrent cancers, an attempt to improve survival with combined nonspecific immunostimulation by the intraperitoneal administration of BCG followed by oral BCG cycled with chemotherapy was studied. The results suggested that a population of patients with gastric and colonic cancers showed improved survival with this treatment. A randomized trial of combined chemoimmunotherapy versus chemotherapy alone was begun on November 1, 1974, for all cancers of the stomach and pancreas and all colorectal cancers beyond stage C by Dukes' classification. The initial results with patients entered by December 31, 1975, and followed until March 1, 1976, are reported.
14
REGIONAL IMMUNOTHERAPY OF LUNG CANCER WITH INTRAPLEURAL B.C.G.
MartinF. Mckneally, Carole Maver, HarveyW. Kausel · The Lancet · 1976 · 187 citations
Medicine, Immunology, Oncology +8
TREATMENT AFTER EXPOSURE TO COLD
RogerT Gregory, JohnF Patton, Jonathan Whitby et al. · The Lancet · 1972 · 162 citations
Corynebacterium parvum as an immunotherapeutic anticancer agent.